Background
Methods
Selection of samples
Fitness assay and mutation rate
Extraction of DNA and whole-genome sequencing
Bioinformatics analysis
Results
Type | Isolate | Lineage (clade) | Resistant to | Sensitive to | Polymorphism for INH | Relative fitness to H37Rv |
---|---|---|---|---|---|---|
Cluster RFL15 | 02.113 | Euro American (Cameroon) | - | H,R,Z,E,S | None detected | 0.96 |
02.292
|
Euro American (Cameroon)
|
H
|
R,Z,E,S
|
inhA C → T
|
0.88
| |
02:302a | Euro American | S | H,R,Z,E | None detected | 1.05 | |
03.013 | Euro American (Cameroon) | S | H,R,Z,E | None detected | 0.89 | |
03.039
|
Euro American (Cameroon)
|
H
|
R,Z,E,S
|
inhA C → T
|
0.82
| |
03.303a | Euro American | H | R,Z,E,S |
inhA C → T
| 0.92 | |
03.313 | Euro American (Cameroon) | S | H,R,Z,E | None detected | 0.98 | |
04.018
|
Euro American (Cameroon)
|
H, R, clari, ethi
|
Z,E,S
|
inhA C → T
|
0.75
| |
04.194 | Euro American (Uganda) | H | R,Z,E,S | katG S315T | 0.96 | |
04:198a | Euro American | H | R,Z,E,S |
inhA C → T
| 0.98 | |
04.211
|
Euro American (Cameroon)
|
H
|
R,Z,E,S
|
inhA C → T
|
0.93
| |
04.493
|
Euro American (Cameroon)
|
H
|
R,Z,E,S
|
inhA C → T
|
1.01
| |
04.503
|
Euro American (Cameroon)
|
H
|
R,Z,E,S
|
inhA C → T
|
0.94
| |
05.046 | Euro American (Cameroon) | - | H,R,Z,E,S | None detected | 1.03 | |
07.116
|
Euro American (Cameroon)
|
H, ethi
|
R,Z,E,S
|
inhA C → T
|
0.99
| |
07:118 | Euro American (Cameroon) | H | R,Z,E,S | katG S315T | 0.82 | |
H-resistant control | 05.177 (Control strain 1) | Euro American (Uganda) | H | R,Z,E,S |
inhA C → T
| 0.92 |
H-sensitive control | 05.094 (Control strain 2) | Euro American (Uganda) | - | H,R,Z,E,S | None detected | 0.88 |
H-sensitive control | 04.011 (Control strain 3) | East African Indian (Delhi/CAS) | - | H,R,Z,E,S | katG R463L (but no resistance) | 0.81 |
Mutation rate - outbreak strains
|
Mutation rate - control strains
| |||||
1.3 × 10−8 × cell division | 1.3 × 10−8 × cell division |
Fitness assay and mutation rate
Genetic analysis
Deletions
Genes name (function) | Isolates: 02.292, 03.039, 04.018, 04.211, 04.493, 04.503, 07.116 | 03.313 | 05.177 Control |
---|---|---|---|
Phirv1 phage proteins (part of genomic island) | ✘ | ✘ | ✓ |
Rv1673c (conserved hypothetical protein) | ✘ | ✘ | ✓ |
Rv1675c (probable cAMP and macrophage regulator) | ✘ | ✘ | ✓ |
plcD (phosphoesterase) | ✘ | ✘ | ✓ |
Wag22 (antigen member, PE family) | ✘ | ✘ | ✓ |
Rv1760 (possible triacylglycerol synthase) | ✘ | ✘ | ✓ |
Rv1761c (unknown protein) | ✘ | ✘ | ✓ |
Rv1762c (unknown protein) | ✘ | ✘ | ✓ |
plcB (phosphoesterase) | ✘ | ✓ | ✓ |
plcA (membrane associated phospholipase) | ✘ | ✓ | ✓ |
PPE54 (part of PPE family) | ✘ | ✓ | ✓ |
PE_PGRS50 (antigen member, PE family) | ✘ | ✘ | ✓ |
PPE55 (part of PPE family) | ✘ | ✘ | ✓ |
Rv3349c (probable transposase) | ✘ | ✘ | ✓ |
Rv3371 (possible triacylglycerol synthase) | ✘ | ✘ | ✓ |
Rv3486 (membrane protein, function unknown) | ✘ | ✘ | ✓ |
Single nucleotide polymorphisms
Gene name | Function | Result | S/NS | Position | Amino acid change |
---|---|---|---|---|---|
ctpA
| Cation transporting P-type ATPase | Reduced CFUs | NS | 100895 | A/S |
ctpI
| Cation transporting P-type ATPase | Reduced CFUs | S | 130449 | A/A |
mce1F
| Mce protein | Reduced tissue pathology and increased survival | NS | 206453 | G/A |
Rv0176
| Mce protein | Reduced CFUs, reduced tissue pathology, and increased survival | NS | 208299 | P/R |
pckA
| Iron-regulated phosphoenolpyruvate carboxykinase | Reduced CFUs | NS | 252105 | M/I |
pcaA
| Mycolic acid cyclopropane synthase | Reduced CFUs in lung | NS | 561021 | H/Y |
pstS1
| phosphate-binding lipoprotein component of inorganic phosphate transport system | Reduced multiplication | NS | 1042991 | P/A |
mprB
| Two component sensor kinase | Reduced CFUs in lung latent stage | S | 1098698 | G/G |
oppA
| Oligopeptide-binding lipoprotein component of peptide transport system | Reduced CFUs in organs in the chronic infection, increased survival | S | 1433114 | G/G |
oppD
| Oligopeptide-transport ATP binding protein | Reduced CFUs in organs in the chronic infection, increased survival | S | 1434648 | V/V |
irtA
| Iron-regulated transporter | Reduced CFUs in macrophages and lung | S | 1514732 | R/R |
irtB
| Iron-regulated transporter | Reduced CFUs in macrophages and lung | S | 1515922 | V/V |
Rv1410c
| Aminoglycoside/tetracycline-transport integral membrane protein | Reduced CFUs | S | 1586360 | A/A |
pks5
| Polyketide synthase | Reduced CFUs in organs | S | 1726541 | Y/Y |
eccB5
| EsX-5 type VII secretion system protein | Reduced CFUs | S | 2017898 | T/T |
eccD5
| EsX-5 type VII secretion system protein | Reduced CFUs | S | 2032701 | A/A |
mycP5
| Pro-rich membrane-anchored serine protease (mycosin) | Reduced CFUs | NS | 2033748 | G/A |
katG
| Catalase peroxidase peroxynitritase T | Reduced CFUs, resistance to INH | S | 2155389 | P/P |
Rv1931c
| Probable transcriptional regulatory protein | Reduced CFUs | S | 2183054 | G/G |
fadE18
| Acyl-CoA dehydrogenase | Reduced CFUs | S | 2184781 | G/G |
mce3A
| Mce protein, ? virulence factor | Reduced tissue pathology and increased survival | S | 2210055 | T/T |
dosT
| Histidine kinase response regulator | Moderate reduction CFUs | S | 2273627 | G/G |
pks12
| Polyketide synthase | Reduced CFUs | S | 2294876 | R/R |
pafA
| Proteasome accessory factor A | Reduced CFUs in organs and less tissue pathology | S | 2355511 | V/V |
mpa
| Proteasone ATPase | Reduced CFUs in organs and less tissue pathology | S | 2375883 | K/K |
Rv3083
| Probable monooxygenase | Reduced CFUs | NS | 3448567 | H/D |
nuoG
| NADH dehydrogenase | Increased animal survival and reduced CFUs in organs | S | 3518089 | G/G |
Rv3236c
| Probable conserved integral membrane transport protein | Reduced phagosome ROS production | S | 3612571 | V/V |
ponA2
| Penicillin-binding protein | Moderate reduction in CFUs | NS | 4122882 | R/S |
mmpL8
| Predicted drug exporter of the RND superfamily | Reduced CFUs in organs | S | 4291134 | R/R |
esxA
| Early secretory antigenic target | Reduced CFUs | S | 4352875 | N/N |
eccE2
| Type VII secretion system protein | Reduced CFUs | NS | 4367659 | V/A |
eccE2
| Type VII secretion system protein | Reduced CFUs | NS | 4367911 | I/T |
Insertions
Discussion
-
Rv1675c is a transcription factor known to be responsive to cAMP levels, and implicated in the biology of persistent TB infection [30]. It is a regulator of four different protein genes (mdh, groEL2, Rv1265, and PE_PGRS6a) during macrophage infection by MTB and they are likely to play a role in MTB-host interactions [31].
-
the MTB genome contains four different plc genes (plcA, plcB, plcC, and plcD) that encode for the enzyme phospholipase C (PLC). This region frequently contains deletions [32]. The absence/altered function of these genes could in some way influence the overall PLC activity, resulting in an impaired ability to degrade the phagosome membrane and consequent persistence of the bacterium inside the macrophages. Alternatively, a reduction in the release of arachidonic acid could lead to a decreased influx of inflammatory cells to the first site of infection, thus allowing the MTB to partially escape an early immune response. It is probable that PLC is involved in a number of different mechanisms and is one part of a complex system that allows MTB to survive inside macrophages and sustain chronic infection [33‐35].